{"id":"https://openalex.org/W7225265684","doi":"https://doi.org/10.3389/fonc.2026.1958236","title":"Pharmacokinetic and dosimetric evaluation of [177Lu]Lu-FAPI for stromal-targeted radionuclide therapy in triple-negative breast cancer: a preclinical biodistribution and dosimetry study","display_name":"Pharmacokinetic and dosimetric evaluation of [177Lu]Lu-FAPI for stromal-targeted radionuclide therapy in triple-negative breast cancer: a preclinical biodistribution and dosimetry study","publication_year":2026,"publication_date":"2026-11-04","ids":{"openalex":"https://openalex.org/W7225265684","doi":"https://doi.org/10.3389/fonc.2026.1958236"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1958236","doi":"https://doi.org/10.3389/fonc.2026.1958236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1958236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1958236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1958236/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160629746","display_name":"Zhihua Tang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160695","display_name":"Shaoxing People's Hospital","ror":"https://ror.org/05v58y004","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160695"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhihua Tang","raw_affiliation_strings":["Department of Pharmacy, Shaoxing People\u2019s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)","Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Shaoxing People\u2019s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)","institution_ids":["https://openalex.org/I4210160695","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University","institution_ids":["https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021384214","display_name":"\u4f59\u9732\u5c71","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lushan Yu","raw_affiliation_strings":["College of Pharmaceutical Sciences, Zhejiang University","Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmaceutical Sciences, Zhejiang University","institution_ids":["https://openalex.org/I76130692"]},{"raw_affiliation_string":"Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University","institution_ids":["https://openalex.org/I76130692"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160667000","display_name":"Ke Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160695","display_name":"Shaoxing People's Hospital","ror":"https://ror.org/05v58y004","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160695"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ke Zhang","raw_affiliation_strings":["Department of Pharmacy, Shaoxing People\u2019s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Shaoxing People\u2019s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)","institution_ids":["https://openalex.org/I4210160695","https://openalex.org/I76130692"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021384214","https://openalex.org/A5160667000"],"corresponding_institution_ids":["https://openalex.org/I4210160695","https://openalex.org/I76130692"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85811217,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7577999830245972},{"id":"https://openalex.org/C75088862","wikidata":"https://www.wikidata.org/wiki/Q2291081","display_name":"Dosimetry","level":2,"score":0.6546000242233276},{"id":"https://openalex.org/C111798993","wikidata":"https://www.wikidata.org/wiki/Q21117471","display_name":"Fibroblast activation protein, alpha","level":3,"score":0.6395000219345093},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.6121000051498413},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.5526999831199646},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5508999824523926},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5194000005722046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5160999894142151},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.48669999837875366},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.460099995136261},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3628999888896942},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.35120001435279846},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33500000834465027},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.3246999979019165},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.32350000739097595},{"id":"https://openalex.org/C151337348","wikidata":"https://www.wikidata.org/wiki/Q215313","display_name":"Absorbed dose","level":3,"score":0.3124000132083893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.298799991607666},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.2791000008583069},{"id":"https://openalex.org/C52124034","wikidata":"https://www.wikidata.org/wiki/Q557179","display_name":"Stroma","level":3,"score":0.2676999866962433}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fonc.2026.1958236","doi":"https://doi.org/10.3389/fonc.2026.1958236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1958236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1958236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1958236","doi":"https://doi.org/10.3389/fonc.2026.1958236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1958236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1958236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225265684.pdf","grobid_xml":"https://content.openalex.org/works/W7225265684.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1952391983","https://openalex.org/W2002145465","https://openalex.org/W2032747682","https://openalex.org/W2047764904","https://openalex.org/W2048253455","https://openalex.org/W2114505219","https://openalex.org/W2125071971","https://openalex.org/W2134539328","https://openalex.org/W2170602872","https://openalex.org/W2529926810","https://openalex.org/W3012530083","https://openalex.org/W3167796732","https://openalex.org/W3210491826","https://openalex.org/W4225366649","https://openalex.org/W4253483429","https://openalex.org/W4281400179","https://openalex.org/W4362659700","https://openalex.org/W4385850944","https://openalex.org/W4387393142","https://openalex.org/W4412078524","https://openalex.org/W4412535172","https://openalex.org/W4413230096","https://openalex.org/W7160199031"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Triple-negative":[1],"breast":[2],"cancer":[3],"(TNBC)":[4],"has":[5],"limited":[6],"targeted":[7],"treatment":[8],"options":[9],"and":[10,53,57,75,78,148,168,186,207,223,241,271,288],"is":[11],"strongly":[12],"influenced":[13],"by":[14],"stromal":[15,42],"biology.":[16],"This":[17],"study":[18],"evaluated":[19],"[":[20,35,136,264,292],"177":[21,36,137,265,293],"Lu]Lu-FAPI":[22,37,138,266,294],"for":[23,195,239,246,291],"fibroblast":[24,199],"activation":[25],"protein-alpha":[26],"(FAP)-directed":[27],"tumor":[28,227,240],"microenvironment":[29],"targeting":[30],"in":[31,48,166,172,295,304],"TNBC":[32,41,127,269],"models.":[33],"Methods":[34],"was":[38,105,253],"assessed":[39],"using":[40],"FAP":[43,131],"analysis,":[44],"radiochemical":[45,140],"quality":[46],"control,":[47],"vitro":[49],"stability,":[50],"cellular":[51],"uptake":[52,211],"blocking":[54],"assays,":[55],"internalization":[56],"retention":[58],"studies,":[59],"serial":[60],"biodistribution,":[61],"Single-photon":[62],"emission":[63],"computed":[64],"tomography/computed":[65],"tomography":[66],"(SPECT/CT),":[67],"autoradiography,":[68],"Medical":[69],"Internal":[70],"Radiation":[71],"Dose":[72],"(MIRD)-based":[73],"dosimetry,":[74,274],"preliminary":[76],"systemic":[77],"histologic":[79],"safety":[80],"evaluation.":[81],"The":[82,249],"DOTA-FAPI-04":[83],"precursor":[84],"(FAPI-4;":[85],"CAS":[86],"2374782-02-0;":[87],"molecular":[88,101],"formula":[89],"C":[90],"40":[91],"H":[92],"54":[93],"F":[94],"2":[95],"N":[96],"10":[97,99],"O":[98],";":[100],"weight,":[102],"872.92":[103],"g/mol)":[104],"obtained":[106],"from":[107],"a":[108,187],"commercial":[109],"supplier":[110],"(MedChemExpress,":[111],"Shanghai,":[112],"China,":[113],"Cat.":[114],"No.":[115],"HY-130196)":[116],"with":[117,133,275],"confirmed":[118,225],"purity":[119,141],"\u226595%":[120],"via":[121,146,152],"high-performance":[122],"liquid":[123],"chromatography":[124,154],"(HPLC).":[125],"Results":[126],"stroma":[128],"showed":[129,139,202,267],"prominent":[130],"expression":[132],"\u03b1-SMA":[134],"co-localization.":[135],"of":[142,181,190],"98.7%":[143],"\u00b1":[144,150,164,170,183,192,236,243],"0.8%":[145],"radio-HPLC":[147],"96.1%":[149],"1.2%":[151],"radio-thin-layer":[153],"(radio-TLC).":[155],"At":[156],"72":[157,214],"h,":[158,215],"intact":[159],"tracer":[160],"remained":[161],"at":[162],"92.1%":[163],"2.7%":[165],"saline":[167],"83.4%":[169],"2.9%":[171],"serum.":[173],"Competitive":[174],"binding":[175],"assays":[176],"revealed":[177],"an":[178],"IC":[179],"50":[180],"12.3":[182],"2.1":[184],"nM":[185,194],"K":[188],"i":[189],"8.7":[191],"1.5":[193],"FAP.":[196],"FAP-positive":[197],"cancer-associated":[198],"(CAF)-like":[200],"cells":[201],"blocking-sensitive":[203],"uptake,":[204],"progressive":[205],"internalization,":[206],"prolonged":[208],"retention.":[209],"Tumor":[210],"persisted":[212],"through":[213],"while":[216],"blood":[217],"activity":[218],"declined":[219],"to":[220,301],"0.02%ID/g.":[221],"SPECT/CT":[222],"autoradiography":[224],"FAP-associated":[226],"localization.":[228],"Revised":[229],"dosimetry":[230],"estimated":[231],"absorbed":[232],"dose":[233],"as":[234,258],"0.73":[235],"0.15":[237],"mGy/MBq":[238,245],"4.83":[242],"0.52":[244],"the":[247,256,259,276,279,286],"kidney.":[248],"tumor-to-kidney":[250],"absorbed-dose":[251],"ratio":[252],"0.15,":[254],"confirming":[255],"kidney":[257,277],"primary":[260],"organ-at-risk":[261,281],"consideration.":[262,282],"Conclusions":[263],"stromal-targeted":[268],"localization":[270],"feasible":[272],"preclinical":[273],"remaining":[278],"main":[280],"These":[283],"findings":[284],"establish":[285],"pharmacokinetic":[287],"dosimetric":[289],"foundation":[290],"TNBC;":[296],"however,":[297],"therapeutic":[298],"efficacy":[299],"remains":[300],"be":[302],"demonstrated":[303],"future":[305],"studies.":[306]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-05T00:00:00"}